StockGlow

Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.

$20.03-0.01%Healthcare
Compare SPTX with
StockGlow Score
84
Bullish
BearishBullish
1 year ago+0.9%

The outlook

Seaport Therapeutics, Inc. currently reads as bullish based on strong buy — 1.5 avg of 5 analysts, above its 50- & 200-day averages, 63% of the way from its 52-week low to high, avg target +90% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Analyst consensusStrong Buy — 1.5 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range63% of the way from its 52-week low to high
Price targetAvg target +90% vs current price

Analyst price target

~12-month · 5 analysts
$38.00average target+89.8% vs now
Now $20.03
Low $30.00High $50.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$1.07B
52-wk high
$23.00
52-wk low
$14.85
50-day avg
$19.09
200-day avg
$18.58
Trailing P/E
—

Similar stocks

COAGHemab Therapeutics Holdings, Inc.$46.38-2.30%AVLNAvalyn Pharma Inc.$28.20-3.80%KLRAKailera Therapeutics, Inc.$16.78-1.58%ODTXOdyssey Therapeutics, Inc.$18.34-0.43%EIKNEikon Therapeutics, Inc.$9.20-4.37%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy